- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Inphact gains $15 million investment from MDS
Inphact gains $15 million investment from MDSMDS, a Canadian provider of laboratory and clinical services and products, has invested $15 million in Inphact, a Nashville, TN-based firm providing imaging and teleradiology services over the
Inphact gains $15 million investment from MDS
MDS, a Canadian provider of laboratory and clinical services and products, has invested $15 million in Inphact, a Nashville, TN-based firm providing imaging and teleradiology services over the Internet. The investment is intended to enable MDS to provide Inphact services on an exclusive basis in Canada and to MDS joint-venture facilities in the U.S. Inphact claims to be the first application service provider in the imaging market and is offering its PACS on a subscription basis over an ASP platform. The foundation of the firms platform is RadWeb, which provides browser-based access to radiology images and reports and the ability to manipulate and enhance digital images. Inphact plans to develop its ASP product for other imaging modalities, starting with cardiology.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
